|
Lentiviral Gene Therapy (Zamtocabtagene Autoleucel) LTFU
RECRUITINGSponsored by Miltenyi Biomedicine GmbH
Actively Recruiting
SponsorMiltenyi Biomedicine GmbH
Started2024-05-15
Est. completion2041-12-01
Eligibility
Age18 Years+
Healthy vol.Accepted
Locations11 sites
View on ClinicalTrials.gov →
NCT06116110
Summary
This is an observational long-term follow-up (LTFU) study for subjects who previously received zamtocabtagene autoleucel, known as MB-CART2019.1.
Eligibility
Age: 18 Years+Healthy volunteers accepted
Inclusion Criteria: * Received zamtocabtagene autoleucel in a North American Miltenyi Biomedicine-sponsored clinical study and have not withdrawn consent to be followed or been deemed lost to follow-up. * Provided written informed consent to participate in this study. Exclusion Criteria: * None
Conditions7
CancerCentral Nervous System LymphomaHigh-grade B-cell LymphomaNon-hodgkin LymphomaPrimary Mediastinal B-cell Lymphoma (PMBCL)Refractory Diffuse Large B-cell Lymphoma (DLBCL)Relapsed Diffuse Large B Cell Lymphoma
Locations11 sites
Find trials near these locations
Cancer trials in ChicagoCancer trials in BaltimoreCancer trials in BostonCancer trials in PortlandCancer trials in DallasCancer trials in MilwaukeeAll trials in ArizonaAll trials in CaliforniaAll trials in IllinoisAll trials in MarylandAll trials in MassachusettsAll trials in North CarolinaAll trials in OregonAll trials in TexasAll trials in Wisconsin
Browse More Trials
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.
Actively Recruiting
SponsorMiltenyi Biomedicine GmbH
Started2024-05-15
Est. completion2041-12-01
Eligibility
Age18 Years+
Healthy vol.Accepted
Locations11 sites
View on ClinicalTrials.gov →
NCT06116110